Forward-deployed engineers install it in your environment, where it connects study inputs, SDTM mapping, ADaM derivations, tables, listings, figures, and review in one workflow.
Source-reported As recorded 2026-11-11
Browser storage is unavailable. Keep this page open and export your collection before leaving.
Biotech pharma
Astraea
Overview
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.
Company description As recorded 2026-11-08
Product & workflow
Founders & team
Joshua Wang
Founder/CEOStanford dropout previously studying CS and Math. Top 250 united states (USAMO) Qualifier, USACO Platinum, first intern at Salient (W23) developing enterprise systems.
Founder profile As recorded 2026-09-15
Sanmay Sarada
Founder/CTOprev Data Engineer @ Baylor College of Medicine | 4 Publications in Fetal Medicine | CS and Bio at Stanford
Founder profile As recorded 2026-09-15
2team members reported
Source-reported As recorded 2026-09-15
Founded 2026 · Source
News & product activity
Cohort membership
Spring 2026Spring 2026
Original evidence ↗Sources & observations
Profile depthenriched profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedSan Francisco, CA, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
- Product overviewSource description Checked 2026-11-11
- Product visualsNot documented
- Founders & originsTeam information
- Business model & pricingNot documented
- Funding & ownershipNot documented
- Dated milestonesDated source activity: 2026 Q2 (quarter only)
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding yearrecent publishing observed
Similar businesses
Atlas Discovery is an AI-native pharma company. Our biomedical AI agents connect existing knowledge to identify drug-rescue opportunities for rare diseases.
Founders · How it works
- Founded
- 2026
- Team
- 3 people
Same product type · Industry software
abinitio bio is the AI-native operating platform for drug development and manufacturing.
Founders · Product · How it works
- Founded
- 2026
- Team
- 2 people
Same category · Biotech pharma
Our autonomous biodefense capabilities ensure validated point-of-care diagnostics for emerging biological threats are developed in days, not 12+ months.
Founders
- Founded
- 2024
- Team
- 3 people
Same category · Biotech pharma
Anthrogen is engineering post-modality biology. Today's modalities reflect historical contingencies in biological progress, not fundamental categories. We develop the AI systems that design modular biological machines and the…
Founders · Product
- Founded
- 2024
- Team
- 15 people
Same category · Biotech pharma
Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving…
Founders · Product
- Founded
- 2025
- Team
- 4 people
Same category · Biotech pharma
Generative AI Medical Writing Solution for Biotech, Life Sciences, Pharma & Medical Devices | Artos AI. Book a demo online.
Customers · Founders · Product
- Founded
- 2023
- Team
- 7 people
Same category · Biotech pharma